The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank.
The musculoskeletal healthcare company continues to try to turn things around, with limited success in the first quarter. New daily records for COVID-19 cases and hospitalizations mean these stocks are probably headed in opposite directions. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index how to invest in mining stocks (Market Barometer) quotes are real-time. This site is protected by reCAPTCHA and the Google
Terms of Service apply. We’d like to share more about how we work and what drives our day-to-day business. The “Halftime Report” traders give their top picks to watch for the second half.
Invest in ZBH
240 employees have rated Zimmer Biomet Chief Executive Officer Bryan Hanson on Glassdoor.com. Bryan Hanson has an approval rating of 87% among the company’s employees. 66.0% of employees surveyed would recommend working at Zimmer Biomet to a friend.
And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page. In terms of business category, Global Knees grew 10.5% in the second quarter of 2023, driven by the strong execution of the company’s four-pillar strategy. It was backed by a robust Persona portfolio, combined with the benefits of the ROSA robotics platform. Global Hips grew 4.9% on the back of new product flow, execution and market recovery. Zimmer Biomet has been witnessing a rebound in its business in the past few quarters despite macroeconomic challenges.
Choose how much you’d like to invest in ZBH stock
Barclays on Monday reinstates coverage of Club holding Emerson Electric (EMR), with a $105-per-share price target and equal weight rating. Meanwhile, Argus upgrades Emerson to buy, from hold, with a $110-per-share price target. For more insight on analysts targets of ZBH, see our ZBH price target page.
- The orthopedic industry is highly competitive, with a few major players dominating the market.
- Zimmer Biomet’s (ZBH Quick QuoteZBH – Free Report) strategic spin-off of the non-core dental and spine business and stabilizing market trends bolster our confidence in the stock.
- Get this delivered to your inbox, and more info about our products and services.
Shares of the company have increased 31% in the past year compared with the industry’s rise of 1.9%. Zimmer Biomet is expanding its product portfolio through innovation and acquisitions. The company has a robust pipeline of new products in development, including the Persona Revision Knee System and the ROSA Knee System. Zimmer Biomet is also pursuing strategic acquisitions to expand its presence in emerging markets and strengthen its position in existing markets.
Poaches Zimmer Biomet CEO Hanson to Lead Healthcare Spinoff >MMM ZBH
Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat’s FREE daily newsletter. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more. Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services. As elective surgery candidates return to operating rooms, revenue will ramp up.
The consensus among Wall Street equities research analysts is that investors should “hold” ZBH shares. A hold rating indicates that analysts believe investors should maintain any existing https://investmentsanalysis.info/ positions they have in ZBH, but not buy additional shares or sell existing shares. SIBN’s earnings beat estimates in all the trailing four quarters, the average surprise being 20.37%.
Stryker, NextEra Energy And A Stock Down 18% In Past Month: CNBC’s ‘Final Trades’
For example, the increasing popularity of non-surgical treatments for orthopedic conditions could affect the demand for joint replacement products. The company’s hip and knee replacement products continue to enjoy solid demand. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
According to the company, procedure recovery continues successfully, aided by no meaningful impact from COVID or staffing challenges. Accordingly, the company is benefiting from increased provider capacity, resulting in backlog pull-through in recent quarters. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account.
Zimmer Biomet Hlds Stock Earnings
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.32% per year. These returns cover a period from January 1, 1988 through July 31, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return.
The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month.